Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Publication | Closed Access

DOI

2.4K

Citations

References

2019

Year

Salah‐Eddin Al‐Batran, Nils Homann, Claudia Pauligk, Thorsten Oliver Goetze, Stefan Kasper, Hans‐Georg Kopp, Frank Mayer, Georg Martin Haag, Kim Barbara Luley, Udo Lindig,

The Lancet

Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicineVersus FluorouracilResectable GastricGastroenterologyPerioperative ChemotherapySurgeryCancer TreatmentOncologyRadiation Oncology